← Leaderboards
Mark S. Pankonin
Wayne State University
$214,780
Attributed
$214,780
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $41.4K · FY2005–07$50K$37.5K$25K$12.5K$0
'05
'06
'07
Funding mix
By agency
NIH$214,780 · 1
By mechanism
F30$214,780 · 1
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Robert P Skoff$4,188,057
- Jun Li$7,226,441
- Michael E Shy$19,396,125
- Nicholas G Davis$2,295,223
- Alexander Gow$5,007,537
Others in their field
Top investigators on “Point Mutation”
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard K. Wilson · Washington University$45,224,621
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- David Manuel Valenzuela · Regeneron Pharmaceuticals, Inc.$25,346,919
- John H Krystal · Yale University$19,789,874
- Brian Richard Smith · Yale University$19,789,874
Research focus
Point MutationPathologic ProcessMagnetic Resonance ImagingLaboratory MouseDisease /Disorder ModelTissue /Cell CultureAxonLight MicroscopyMyelinHistopathologyNeurophysiologyNuclear Magnetic Resonance SpectroscopyImmunocytochemistryMyelinopathyMyelin ProteolipidLeukodystrophyGene ExpressionAspartateMolecular PathologyNeural DegenerationHuman SubjectClinical ResearchEtiologyDysmyelination
Grant awards (6)
Role of Heparin Sulfate in Neuregulin Signaling during Development and in Disease$38,280
F30 · FY2007 · NS · contact PI
Role of Heparin Sulfate in Neuregulin Signaling during Development and in Disease$41,432
F30 · FY2006 · NS · contact PI
Role of Heparin Sulfate in Neuregulin Signaling during Development and in Disease$35,027
F30 · FY2005 · NS
Role of Heparin Sulfate in Neuregulin Signaling during Development and in Disease$34,089
F30 · FY2004 · NS
Role of Heparin Sulfate in Neuregulin Signaling during Development and in Disease$32,433
F30 · FY2003 · NS
Determinants of Disease Severity in PMD$33,519
F30 · FY2002 · NS